Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| AMGEN | 7 | 27 | +2,07 % | ||
| KYMERA THERAPEUTICS | 7 | 6 | -0,71 % | ||
 | NOVOCURE | 6 | 11 | +23,69 % | |
| ALNYLAM PHARMACEUTICALS | 6 | 9 | +1,20 % | ||
| PHATHOM PHARMACEUTICALS | 6 | 2 | -5,43 % | ||
| BIOGEN | 5 | 54 | -3,51 % | ||
| UNIQURE | 5 | - | +15,88 % | ||
| AXSOME THERAPEUTICS | 4 | 1 | +12,27 % | ||
| AC IMMUNE | 4 | - | +1,39 % | ||
| BIONTECH | 3 | 13 | +1,38 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 00:30 | Amgen Q1 2026 slides: 16 brands fuel growth despite patent headwinds | 4 | Investing.com | ||
| 00:24 | Illumina Q1 Profit Rises On Higher Revenue, Improved Margins | 213 | AFX News | SAN DIEGO (dpa-AFX) - Illumina Inc. (ILMN) on Thursday reported first-quarter results, with profit increasing from last year, driven by higher revenue and improved margins. Revenue for the quarter... ► Artikel lesen | |
| 00:00 | Amgen achieves Q1 double beat; 2026 guidance ranges meet expectations | 3 | Seeking Alpha | ||
| Do | Transcript: Amgen Q1 2026 Earnings Conference Call | 2 | Benzinga.com | ||
| Do | Pacira Q1 2026 slides: EXPAREL growth accelerates amid pipeline progress | 2 | Investing.com | ||
| Do | Pacira BioSciences Q1 2026 Earnings Call Transcript | 2 | Benzinga.com | ||
| Do | Amgen hebt Jahresprognose an - Quartalszahlen etwa wie erwartet | 353 | dpa-AFX | THOUSAND OAKS (dpa-AFX) - Der US-Biotechkonzern Amgen blickt trotz zunehmender Konkurrenz zuversichtlicher auf das laufende Jahr. 2026 werde der Umsatz bei 37,1 bis 38,5 Milliarden Dollar liegen, teilte... ► Artikel lesen | |
| Do | Ardelyx vor Quartalszahlen: Reicht das IBSRELA-Wachstum für den Weg in die Gewinnzone? | 2 | Investing.com Deutsch | ||
| Do | Syndax Pharmaceuticals: Quartalszahlen im Fokus des zunehmenden Wettbewerbs | 1 | Investing.com Deutsch | ||
| Do | Recursion Pharmaceuticals: Recursion Announces Board Transition | 6 | GlobeNewswire (USA) | ||
| Do | Alvotech Announces a Change in its Executive Team | 4 | GlobeNewswire (USA) | ||
| Do | Amgen (AMGN) Q1 Earnings and Revenues Beat Estimates | 11 | Zacks | ||
| Do | Amgen Inc. Bottom Line Rises In Q1 | 229 | AFX News | THOUSAND OAKS (dpa-AFX) - Amgen Inc. (AMGN) announced a profit for its first quarter that Increases, from last yearThe company's bottom line came in at $1.819 billion, or $3.34 per share. This... ► Artikel lesen | |
| Do | Axsome Therapeutics, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| Do | Amgen Non-GAAP EPS of $5.15 beats by $0.38, revenue of $8.62B beats by $50M | 20 | Seeking Alpha | ||
| Do | Pacira BioSciences Non-GAAP EPS of $0.60 beats by $0.04, revenue of $177M beats by $3.66M | 2 | Seeking Alpha | ||
| Do | Prothena Corporation plc: Prothena to Report First Quarter 2026 Financial Results on May 7 | 197 | Business Wire | Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced... ► Artikel lesen | |
| Do | Summit Therapeutics Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| Do | Summit Therapeutics Inc. - 8-K, Current Report | - | SEC Filings | ||
| Do | Phathom outlines $320M-$345M 2026 revenue as it targets operating profitability by Q3 | 1 | Seeking Alpha |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.